Paradigm shift in migraine management impacted by COVID-19 pandemic and the role of confounding factors inflicting the change

References

1. 1.↵
   1. Gupta A,
   2. Madhavan MV,
   3. Sehgal K,
   4. Nair N,
   5. Mahajan S, et al.

   Extrapulmonary manifestations of COVID-19. Nature Medicine 2020; 26: 1017–1032.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Nepal G,
   2. Rehrig JH,
   3. Shrestha GS,
   4. Shing YK,
   5. Yadav JK,
   6. Ojha R et al.

   Neurological manifestations of COVID-19: a systematic review. Critical Care 2020; 24: 421.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Baykan B,
   2. Ertas M,
   3. Karli N,
   4. Akat-Aktas S,
   5. Uzunkaya O,
   6. Zarifoglu M, et al.

   The burden of headache in neurology outpatient clinics in Turkey. Pain Pract 2007; 7: 313–323.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Lim EC,
   2. Seet RC,
   3. Lee KH,
   4. Wilder-Smith EP,
   5. Chuah BY,
   6. Ong BK, et al.

   Headaches and the N95 face-mask amongst healthcare providers. Acta Neurol Scand 2006; 113:199–202.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Ong JJ,
   2. Bharatendu C,
   3. Goh Y,
   4. Tang JZ,
   5. Sooi KW,
   6. Tan YL, et al.

   Headaches associated with personal protective equipment–A cross-sectional study among frontline healthcare workers during COVID-19. Headache 2020; 60: 864–877.

   OpenUrlCrossRefPubMed
6. 6.↵
   GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018; 17: 954–76.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Silvestro M,
   2. Tessitore A,
   3. Tedeschi G,
   4. Russo A.

   Migraine in the Time of COVID-19. Headache 2020; 60: 988–989.

   OpenUrl
8. 8.↵
   Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013, 33: 629–808.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   Coronavirus: Dubai announces two-week 24-hour curfew as disinfection continues”. Al Arabiya English. 4 April 2020. Retrieved 13 April 2020. from URL: https://english.alarabiya.net/News/gulf/2020/04/04/Coronavirus-Dubai-extends-sterilization-enforces-strict-restrictions-on-movement
10. 10.↵
    1. Bener A,
    2. Swadi H,
    3. Qassimi EM,
    4. Uduman S.

    Prevalence of headache and migraine in schoolchildren in the United Arab Emirates. Ann Saudi Med 1998; 18: 522–524.

    OpenUrlPubMedWeb of Science
11. 11.↵
    GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018; 17: 954–976.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Al-Hashel JY,
    2. Ahmed SF,
    3. Alroughani R.

    Burden of migraine in a Kuwaiti population: a door-to-door survey. J Headache Pain 2017; 18: 105.

    OpenUrl
13. 13.↵
    1. Bener A.

    Frequency of headache and migraine in Qatar. Neuroepidemiology 2006; 27: 61–66.

    OpenUrlPubMed
14. 14.↵
    1. Deleu D,
    2. Khan MA,
    3. Al Shehab TA.

    Prevalence and clinical characteristics of headache in a rural community in Oman. Headache 2002; 42: 963–973.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Lipton RB,
    2. Bigal ME.

    Migraine: epidemiology, impact, and risk factors for progression. Headache 2005; 45: S3–S13.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Herekar AA,
    2. Ahmad A,
    3. Uqaili UL,
    4. Ahmed B,
    5. Effendi J,
    6. Alvi SZ, et al.

    Primary headache disorders in the adult general population of Pakistan – a cross sectional nationwide prevalence survey. J Headache Pain 2017; 18: 28.

    OpenUrl
17. 17.↵
    1. Ayzenberg I,
    2. Katsarava Z,
    3. Sborowski A,
    4. Chernysh M,
    5. Osipova V,
    6. Tabeeva G, et al.

    The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia 32: 373–381.
18. 18.↵
    1. Kulkarni GB,
    2. Rao GN,
    3. Gururaj G,
    4. Stovner LJ,
    5. Steiner TJ.

    Headache disorders and public ill-health in India: prevalence estimates in Karnataka state. J Headache Pain 2015; 16: 67.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Ertas M,
    2. Baykan B,
    3. Orhan EK,
    4. Zarifoglu M,
    5. Karli N,
    6. Saip S, et al.

    One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults. J Headache Pain 2012; 13: 147–157.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Parodi IC,
    2. Poeta MG,
    3. Assini A,
    4. Schirinzi E,
    5. Del Sette P.

    Impact of quarantine due to COVID infection on migraine: a survey in Genova, Italy. Neurol Sci 2020; 41: 2025–2027.

    OpenUrl
21. 21.↵
    1. Delussi M,
    2. Gentile E,
    3. Coppola G,
    4. Prudenzano AM,
    5. Rainero I,
    6. Sances G, et al.

    Investigating the Effects of COVID-19 Quarantine in Migraine: An Observational Cross-Sectional Study from the Italian National Headache Registry (RICe). Front Neurol 2020; 11: 597881.

    OpenUrl
22. 22.↵
    1. Altamura C,
    2. Cevoli S,
    3. Aurilia C,
    4. Egeo G,
    5. Fofi L,
    6. Torelli P, et al.

    Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study. Neurol Sci 2020; 41: 3385–3389.

    OpenUrl
23. 23.↵
    1. Chowdhury D,
    2. Datta D.

    Managing migraine in the times of COVID-19 pandemic. Ann Indian Acad Neurol 2020; 23: S33–S39.

    OpenUrl
24. 24.↵
    1. Dalkara T,
    2. Kılıç K.

    How does fasting trigger migraine? A hypothesis. Curr Pain Headache Rep 2013; 17: 368.

    OpenUrl